FDA to Study Limited Drug Warnings in TV Ads

The Food and Drug Administration (FDA) plans to study whether consumers would benefit if direct-to-consumer television advertising contained a shorter list of drug side effects. Regulations now require TV and radio prescription drug advertisements to list the major risks in an audio or an audio and visual part of the ad. The FDA is waiting for the Office of Management and Budget to sign off on the study, which has a 30-day public comment period. (Source: The Hill).